Abstract
Currently, lung cancer is the most common malignant tumor in the world. The local control (LC) rate is only 20%-40% for patients with local advanced non-small cell lung cancer (NSCLC). Hence, reducing the LC rate and enhancing the overall survival (OS) are pivotal research objectives. However, postoperative adjuvant treatment for patients with early NSCLC with chest wall invasion is still controversial. In this article, the research progress on T3N0-1M0 NSCLC with chest wall invasion was reviewed from the perspectives including anatomical features, types of resection, patterns of failure and postoperative radiotherapy, etc. Key words: Chest wall invasion; Carcinoma, non-small cell lung/radiotherapy; Progress
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
